Wawruszak, A.; Kalafut, J.; Okon, E.; Czapinski, J.; Halasa, M.; Przybyszewska, A.; Miziak, P.; Okla, K.; Rivero-Muller, A.; Stepulak, A.
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells. Cancers 2019, 11, 148.
https://doi.org/10.3390/cancers11020148
AMA Style
Wawruszak A, Kalafut J, Okon E, Czapinski J, Halasa M, Przybyszewska A, Miziak P, Okla K, Rivero-Muller A, Stepulak A.
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells. Cancers. 2019; 11(2):148.
https://doi.org/10.3390/cancers11020148
Chicago/Turabian Style
Wawruszak, Anna, Joanna Kalafut, Estera Okon, Jakub Czapinski, Marta Halasa, Alicja Przybyszewska, Paulina Miziak, Karolina Okla, Adolfo Rivero-Muller, and Andrzej Stepulak.
2019. "Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells" Cancers 11, no. 2: 148.
https://doi.org/10.3390/cancers11020148
APA Style
Wawruszak, A., Kalafut, J., Okon, E., Czapinski, J., Halasa, M., Przybyszewska, A., Miziak, P., Okla, K., Rivero-Muller, A., & Stepulak, A.
(2019). Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells. Cancers, 11(2), 148.
https://doi.org/10.3390/cancers11020148